InvestorsHub Logo
Followers 23
Posts 3137
Boards Moderated 0
Alias Born 08/05/2019

Re: None

Wednesday, 07/05/2023 1:11:04 PM

Wednesday, July 05, 2023 1:11:04 PM

Post# of 98500
July 5, 2023 FORM 8-K

The Company had proactively explored opportunities for acquiring an operating business

The Company has embarked on an exciting initiative to create clinical trials focused on psychedelics. The aim is to develop and bring to market a diverse range of safe and effective therapeutic products based on psychedelics. To support this endeavor, the Company has initiated preliminary discussions with a reputable contract research organization based in Canada. Furthermore, the Company is actively exploring the possibility of expanding its team by adding experienced professionals with a proven track record in running successful clinical trials and bringing products to market.

Additionally, resources will be allocated towards the development of clinical trials on psychedelics, emphasizing the creation and commercialization of a comprehensive portfolio of safe and effective psychedelic-based therapeutic products.

https://www.otcmarkets.com/filing/html?id=16771635&guid=GmD-kaZlBdIkdth
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NHMD News